Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-12

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the efficacy and safety of Cyclo-Z in obese adults with Type 2 diabetes. The trial has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclo-Z

Snippet

Sponsor: NovMetaPharma Co., Ltd. | Conditions: Diabetes Mellitus Type 2 in Obese | Phase 2 | Status: COMPLETED | Results posted: 2018-06-12